DJIA 17,119.03 12.33 0.07%
NASDAQ 4,568.53 -2.11 -0.05%
S&P 500 1,999.98 -0.04 0.00%
market minute promo

50.25 -0.53 (-1.03%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMY $50.25 -1.03%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.95
Previous Close $50.77
Daily Range $50.10 - $50.95
52-Week Range $41.32 - $57.49
Market Cap $83.3B
P/E Ratio 31.53
Dividend (Yield) $1.44 (2.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,185,881
Average Daily Volume 5,952,153
Current FY EPS $1.77





Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website:

News & Commentary Rss Feed

3 Reasons Pfizer Inc.'s Stock Could Fall

Despite rumors about mergers and acquisitions, these three catalysts could wind up pressuring Pfizer's stock and ultimately pushing it lower.

Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

Will This Coverage Initiation Affect Bristol-Myers Squibb (BMY) Stock Today?

Analysts' Actions: Akamai, Bristol-Myers, Eli Lilly, Merck, Pfizer

US Stock Futures Edge Higher Ahead Of Tiffany Earnings

With An Iffy Non-Oncology Pipeline, Roche Pays Up For InterMune

4 Foreign Blue-Chip Stocks With 4% Dividend Yields to Buy

3 Reasons Celgene Corporation's Stock Could Fall

Celgene shares are up more than 1,200% over the past decade. But these three headwinds could be the brick wall that sends its stock lower.

3 Stocks Reiterated As A Buy: BMY, AXP, AMGN

Roche Investors Should Breathe Easier After InterMune Acquisition

See More BMY News...

BMY's Top Competitors

BMY $50.25 (-1.03%)
Current stock: BMY
JNJ $103.24 (-0.19%)
Current stock: JNJ
NVS $90.00 (0.32%)
Current stock: NVS
RHHBY $36.65 (0.10%)
Current stock: RHHBY